Eplerenone does not limit ischemia–reperfusion injury in human myocardial tissue-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eplerenone does not limit ischemia–reperfusion injury in human myocardial tissue

Published:2016-08 Issue: Volume:216 Page:110-113
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

van den Berg T.N.A. (Daniëlle),van Swieten H.A.,Vos J.C.,Verweij V.,Wouterse A.C.,Deinum J.,Morshuis W.J.,Rongen G.A.,Riksen N.P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Myocardial reperfusion injury;Yellon;N. Engl. J. Med.,2007

2. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N. Engl. J. Med.,1999

3. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N. Engl. J. Med.,2003

4. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N. Engl. J. Med.,2011

5. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats;Rochetaing;Can. J. Physiol. Pharmacol.,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of aldosterone inhibitors in cardiac ischemia–reperfusion injury;Canadian Journal of Physiology and Pharmacology;2021-01

2. An Endless Story in Cardiac Ischemia-Reperfusion Injury;INT J GERONTOL;2020

3. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial;American Heart Journal;2019-05

4. The role of mineralocorticoid receptor antagonists in patients with acute myocardial infarction: Is the evidence reflective of modern clinical practice?;Cardiovascular Revascularization Medicine;2018-06

5. Eplerenone pretreatment protects the myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats;Molecular and Cellular Biochemistry;2018-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3